StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Vaccinex's profit margin for the twelve months ending Dec 31, 2024 was -3100.5%. For fiscal 2024 it was -3100.5%, against -3552.8% the year before. The highest annual figure on record is -2486.7% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-3100.5%+452.3
FY2023Dec 31, 2023-3552.8%+3652.6
FY2022Dec 31, 2022-7205.5%−4718.8
FY2021Dec 31, 2021-2486.7%+2129.5
FY2020Dec 31, 2020-4616.2%+1476.2
FY2019Dec 31, 2019-6092.4%−2015.3
FY2018Dec 31, 2018-4077.1%+16725.2
FY2017Dec 31, 2017-20802.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2024Dec 31, 2024-1584.0%+22976.0
Q3 FY2024Sep 30, 2024-11023.1%−10120.9
Q2 FY2024Jun 30, 2024-2427.2%−170.3
Q1 FY2024Mar 31, 2024-3747.1%+5770.9
Q3 FY2023Sep 30, 2023-24560.0%−14148.0
Q1 FY2023Mar 31, 2023-902.2%−128.8
Q4 FY2022Dec 31, 2022-2256.9%−856.2
Q3 FY2022Sep 30, 2022-9518.0%−7626.4
Q3 FY2021Sep 30, 2021-10412.0%+24900.0
Q1 FY2021Mar 31, 2021-773.4%+8872.3
Q3 FY2020Sep 30, 2020-1400.6%+2954.5
Q3 FY2019Sep 30, 2019-1891.6%+1441.2
Q2 FY2019Jun 30, 2019-35312.0%−30067.6
Q1 FY2019Mar 31, 2019-9645.7%–
Q4 FY2018Dec 31, 2018-4355.2%–
Q3 FY2018Sep 30, 2018-3332.8%–
Q2 FY2018Jun 30, 2018-5244.4%–

More Vaccinex figures

See a number that looks wrong?